MYCN and neuroblastoma: Importantly, we uncovered a previously unknown mechanism involved in regulation of GLS2 expression in MYCN-amplified neuroblastoma cells, and identified N-Myc as a novel activator selectively upregulating GLS2 (but not GLS1) expression.